ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Life science fund gets interdisciplinary

by Rick Mullin
January 9, 2017 | APPEARED IN VOLUME 95, ISSUE 2

Digitalis, an investment firm that targets life sciences companies working to combine statistics and computing with traditional chemistry and biology, has launched a $100 million investment fund. The firm is also looking to cofound companies that can solve major health care challenges. “We saw a clear need for a health-focused fund that was not bound strictly in life sciences nor information technology, but rather brought different fields together in new ways,” says founder Geoffrey W. Smith. To date, Digitalis has invested in three firms active in computational microbiome research, T-cell sequencing, and health monitoring.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment